SCHEMBL14148352

SCHEMBL14148352

O=S(=O)(C1CC1)N1CCC([C@H](c2cccc(F)c2)N2CCNCC2)CC1

nearest known ligand 0.42

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 2/20 0.42
OPRD1 P41143 2/20 0.42
SLC6A2 P23975 7/20 0.42
SLC6A4 P31645 5/20 0.42
SLC6A3 Q01959 4/20 0.42
KCNH2 Q12809 2/20 0.41
TACR1 P25103 1/20 0.38
OPRK1 P41145 1/20 0.38
CACNA2D1 P54289 1/20 0.37
CACNA1B Q00975 1/20 0.37
CACNB1 Q02641 1/20 0.37
HTR6 P50406 2/20 0.37
CCL5 P13501 1/20 0.37
CCR5 P51681 1/20 0.37
HTR2C P28335 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13411074 0.84 CCL5 (0.36) OPRM1OPRD1SLC6A2SLC6A4SLC6A3
SCHEMBL13114320 0.84 CCL5 (0.36) OPRM1OPRD1SLC6A2SLC6A4SLC6A3
SCHEMBL13294139 0.84 CCL5 (0.36) OPRM1OPRD1SLC6A2SLC6A4SLC6A3
SCHEMBL13411075 0.77 KDM4E (0.40) OPRM1OPRD1KCNH2OPRK1CCL5
SCHEMBL13481967 0.77 CCR5 (0.37) OPRM1OPRD1SLC6A2KCNH2CCL5
SCHEMBL13481505 0.77 CCR5 (0.37) OPRM1OPRD1SLC6A2KCNH2CCL5
SCHEMBL13481535 0.77 CCR5 (0.37) OPRM1OPRD1SLC6A2KCNH2CCL5
SCHEMBL13481971 0.77 CCR5 (0.37) OPRM1OPRD1SLC6A2KCNH2CCL5
SCHEMBL13294181 0.75 CCL5 (0.40) OPRM1OPRD1KCNH2OPRK1HTR6
SCHEMBL493622 0.75 CACNA2D1 (0.46) SLC6A2SLC6A4SLC6A3KCNH2CACNA2D1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008079284-A1 PROCESS FOR PREPARING CCR-5 RECEPTOR ANTAGONISTS UTILIZING 4-SUBSTITUTED 1-CYCLOPROPANE-SULFONYL-PIPERIDINYL COMPOUNDS SCHERING CORPORATION (US) 2008-07-03 WO disclosed